Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
13.98
+0.14 (1.01%)
At close: Mar 9, 2026, 4:00 PM EDT
13.76
-0.22 (-1.57%)
After-hours: Mar 9, 2026, 6:11 PM EDT
Janux Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 850 | 830 | 3,087 | 495 | 547 | 821 | |
| Market Cap Growth | -60.32% | -73.11% | 523.34% | -9.51% | -33.35% | - | |
| Enterprise Value | -107 | -136 | 2,452 | 170 | 233 | 434 | |
| Last Close Price | 13.84 | 13.80 | 53.54 | 10.73 | 13.17 | 19.73 | |
| PS Ratio | 83.70 | 83.00 | 291.54 | 61.27 | 63.54 | 225.73 | |
| PB Ratio | 0.87 | 0.87 | 3.02 | 1.44 | 1.71 | 2.24 | |
| P/TBV Ratio | 0.87 | 0.87 | 3.02 | 1.44 | 1.71 | 2.24 | |
| EV/Sales Ratio | - | - | 231.60 | 21.08 | 27.00 | 119.25 | |
| Debt / Equity Ratio | 0.02 | 0.02 | 0.02 | 0.07 | 0.08 | 0.00 | |
| Net Debt / Equity Ratio | -0.99 | -0.99 | -0.98 | -0.93 | -0.94 | -1.02 | |
| Net Debt / EBITDA Ratio | 6.07 | 6.07 | 10.35 | 4.50 | 4.55 | 11.42 | |
| Net Debt / FCF Ratio | 11.34 | 11.34 | 22.69 | 6.09 | 6.11 | 20.30 | |
| Asset Turnover | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | |
| Quick Ratio | 38.92 | 38.92 | 59.03 | 26.56 | 19.85 | 29.32 | |
| Current Ratio | 39.04 | 39.04 | 59.21 | 26.80 | 20.14 | 29.46 | |
| Return on Equity (ROE) | -11.48% | -11.48% | -10.09% | -17.53% | -18.36% | -17.50% | |
| Return on Assets (ROA) | -9.55% | -9.55% | -8.57% | -12.25% | -11.27% | -10.39% | |
| Return on Capital Employed (ROCE) | -16.10% | -16.10% | -9.50% | -19.90% | -19.30% | -9.00% | |
| Earnings Yield | -13.57% | -13.69% | -2.23% | -11.77% | -11.52% | -3.98% | |
| FCF Yield | -9.95% | -10.03% | -1.43% | -10.59% | -9.02% | -2.25% | |
| Buyback Yield / Dilution | -15.28% | -15.28% | -22.12% | -6.14% | -76.24% | -2471.20% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.